Abstract
This report describes the first case of naturally acquired inhalation anthrax in the United States since 1976. The patient's clinical course included adjunctive treatment with human anthrax immunoglobulin. Clinical correlation of serologic assays for the lethal factor component of lethal toxin and anti-protective antigen immunoglobulin G are also presented.
MeSH terms
-
Adult
-
Anthrax / diagnosis*
-
Anthrax / therapy*
-
Anthrax Vaccines / administration & dosage*
-
Anthrax Vaccines / immunology
-
Antigens, Bacterial / immunology*
-
Bacillus anthracis / isolation & purification
-
Blood Chemical Analysis
-
Environmental Exposure / adverse effects
-
Enzyme-Linked Immunosorbent Assay
-
Exotoxins / blood
-
Follow-Up Studies
-
Humans
-
Immunoglobulin G / immunology*
-
Immunoglobulin G / metabolism
-
Inhalation
-
Male
-
Risk Assessment
-
Severity of Illness Index
-
Travel
-
United States
Substances
-
Anthrax Vaccines
-
Antigens, Bacterial
-
Exotoxins
-
Immunoglobulin G